Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy
- PMID: 16847086
- PMCID: PMC1539104
- DOI: 10.1128/CMR.00060-05
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy
Abstract
The global tuberculosis (TB) control effort is focused on interrupting transmission of the causative agent, Mycobacterium tuberculosis, through chemotherapeutic intervention in active infectious disease. The insufficiency of this approach is manifest in the inexorable annual increase in TB infection and mortality rates and the emergence of multidrug-resistant isolates. Critically, the limited efficacy of the current frontline anti-TB drug combination suggests that heterogeneity of host and bacillary physiologies might impair drug activity. This review explores the possibility that strategies enabling adaptation of M. tuberculosis to hostile in vivo conditions might contribute to the subversion of anti-TB chemotherapy. In particular, evidence that infecting bacilli are exposed to environmental and host immune-mediated DNA-damaging insults suggests a role for error-prone DNA repair synthesis in the generation of chromosomally encoded antibiotic resistance mutations. The failure of frontline anti-TB drugs to sterilize a population of susceptible bacilli is independent of genetic resistance, however, and instead implies the operation of alternative tolerance mechanisms. Specifically, it is proposed that the emergence of persister subpopulations might depend on the switch to an altered metabolic state mediated by the stringent response alarmone, (p)ppGpp, possibly involving some or all of the many toxin-antitoxin modules identified in the M. tuberculosis genome.
Figures
Similar articles
-
Actionable mechanisms of drug tolerance and resistance in Mycobacterium tuberculosis.FEBS J. 2024 Oct;291(20):4433-4452. doi: 10.1111/febs.17142. Epub 2024 Apr 27. FEBS J. 2024. PMID: 38676952 Review.
-
Drug resistance mechanisms and novel drug targets for tuberculosis therapy.J Genet Genomics. 2017 Jan 20;44(1):21-37. doi: 10.1016/j.jgg.2016.10.002. Epub 2016 Oct 11. J Genet Genomics. 2017. PMID: 28117224 Review.
-
The past, present and future of tuberculosis treatment.Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Dec 25;51(6):657-668. doi: 10.3724/zdxbyxb-2022-0454. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36915970 Free PMC article. Review. English.
-
Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.Tuberculosis (Edinb). 2018 May;110:36-43. doi: 10.1016/j.tube.2018.02.009. Epub 2018 Mar 1. Tuberculosis (Edinb). 2018. PMID: 29779771
-
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.Semin Immunopathol. 2016 Mar;38(2):167-83. doi: 10.1007/s00281-015-0537-x. Epub 2015 Oct 28. Semin Immunopathol. 2016. PMID: 26510950 Free PMC article. Review.
Cited by
-
Spatiotemporal perspectives on tuberculosis chemotherapy.Curr Opin Microbiol. 2023 Apr;72:102266. doi: 10.1016/j.mib.2023.102266. Epub 2023 Feb 4. Curr Opin Microbiol. 2023. PMID: 36745965 Free PMC article. Review.
-
Triazaspirodimethoxybenzoyls as selective inhibitors of mycobacterial lipoamide dehydrogenase.Biochemistry. 2010 Mar 2;49(8):1616-27. doi: 10.1021/bi9016186. Biochemistry. 2010. PMID: 20078138 Free PMC article.
-
Secreted acid phosphatase (SapM) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in guinea pig tissues.PLoS One. 2013 Jul 26;8(7):e70514. doi: 10.1371/journal.pone.0070514. Print 2013. PLoS One. 2013. PMID: 23923000 Free PMC article.
-
Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control.Curr Drug Deliv. 2019;16(5):400-429. doi: 10.2174/1567201816666190201144815. Curr Drug Deliv. 2019. PMID: 30714523 Free PMC article. Review.
-
Homology modeling, molecular docking and DNA binding studies of nucleotide excision repair UvrC protein from M. tuberculosis.Protein J. 2013 Aug;32(6):467-76. doi: 10.1007/s10930-013-9506-1. Protein J. 2013. PMID: 23963890
References
-
- Adams, L. B., M. C. Dinauer, D. E. Morgenstern, and J. L. Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78:237-246. - PubMed
-
- Akaki, T., H. Tomioka, T. Shimizu, S. Dekio, and K. Sato. 2000. Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis. Clin. Exp. Immunol. 121:302-310. - PMC - PubMed
-
- Alonso, A., E. Campanario, and J. L. Martínez. 1999. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145:2857-2862. - PubMed
-
- Andersson, D. I. 2003. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6:452-456. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical